5,0
19 apr 2017
Dipendente anonimo
Dipendente attuale, più di 3 anni
Dallas, TX
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Excellent, stable, innovative post-acute company in 29 states with expertise with joint ventures with hospitals & health systems. Joint ventures with health systems. Quality. Innovative. Fiscally sound with solid, personable leadership. Adaptable. Patient-centered focus. Accessible. Visionary. Think outside the box. Leader in post acute
Svantaggi
Seen a lot of growth and have improved in the ability to handle acquisitions & adjust quickly. This hasn't always been the case.